These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 33582663)
1. Effects of Polymyxin B Hemoperfusion on Septic Shock Patients Requiring Noradrenaline: Analysis of a Nationwide Administrative Database in Japan. Fujimori K; Tarasawa K; Fushimi K Blood Purif; 2021; 50(4-5):560-565. PubMed ID: 33582663 [TBL] [Abstract][Full Text] [Related]
2. Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock: a propensity-matched cohort study. Nakamura Y; Kitamura T; Kiyomi F; Hayakawa M; Hoshino K; Kawano Y; Yamasaki R; Nishida T; Mizunuma M; Ishikura H; Crit Care; 2017 Jun; 21(1):134. PubMed ID: 28592318 [TBL] [Abstract][Full Text] [Related]
3. Potential Survival Benefit of Polymyxin B Hemoperfusion in Septic Shock Patients on Continuous Renal Replacement Therapy: A Propensity-Matched Analysis. Iwagami M; Yasunaga H; Noiri E; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Nangaku M; Doi K Blood Purif; 2016; 42(1):9-17. PubMed ID: 26918904 [TBL] [Abstract][Full Text] [Related]
4. Postoperative polymyxin B hemoperfusion and mortality in patients with abdominal septic shock: a propensity-matched analysis. Iwagami M; Yasunaga H; Doi K; Horiguchi H; Fushimi K; Matsubara T; Yahagi N; Noiri E Crit Care Med; 2014 May; 42(5):1187-93. PubMed ID: 24365858 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of postoperative polymyxin B hemoperfusion in secondary peritonitis patients with septic shock: a propensity-matched analysis. Yuan KC; Wang SY; Yu MC; Hsu YP; Pan HC; Chen YC Int J Artif Organs; 2017 Feb; 39(12):603-610. PubMed ID: 28165586 [TBL] [Abstract][Full Text] [Related]
7. Lactate predicts the 28-day survival rate in patients with septic shock treated with the combination of PMX-DHP and rTM. Yamato M; Asahina Y; Koizumi S; Shigeki T; Yajima A; Kimura Y; Iwatani H Ther Apher Dial; 2020 Oct; 24(5):492-498. PubMed ID: 32524733 [TBL] [Abstract][Full Text] [Related]
8. Polymyxin B hemoperfusion in endotoxemic septic shock patients without extreme endotoxemia: a post hoc analysis of the EUPHRATES trial. Klein DJ; Foster D; Walker PM; Bagshaw SM; Mekonnen H; Antonelli M Intensive Care Med; 2018 Dec; 44(12):2205-2212. PubMed ID: 30470853 [TBL] [Abstract][Full Text] [Related]
9. Effects of polymyxin B hemoperfusion in patients with sepsis requiring continuous hemodiafiltration: Analysis of a nationwide administrative database in Japan. Fujimori K; Tarasawa K; Fushimi K Ther Apher Dial; 2021 Aug; 25(4):384-389. PubMed ID: 33885232 [TBL] [Abstract][Full Text] [Related]
10. VASOPRESSOR REDUCTION EFFECT OF POLYMYXIN B HEMOPERFUSION IN PATIENTS WITH PERITONITIS-INDUCED SEPTIC SHOCK: A PROPENSITY SCORE-MATCHED ANALYSIS. Cho A; Oh SY; Lee H; Ryu HG Shock; 2024 Jul; 62(1):69-73. PubMed ID: 38661146 [TBL] [Abstract][Full Text] [Related]
11. A longer duration of polymyxin B-immobilized fiber column hemoperfusion improves pulmonary oxygenation in patients with septic shock. Mitaka C; Tsuchida N; Kawada K; Nakajima Y; Imai T; Sasaki S Shock; 2009 Nov; 32(5):478-83. PubMed ID: 19295483 [TBL] [Abstract][Full Text] [Related]
12. Time to initiation of treatment with polymyxin B cartridge hemoperfusion in septic shock patients. Takeyama N; Noguchi H; Hirakawa A; Kano H; Morino K; Obata T; Sakamoto T; Tamai F; Ishikura H; Kase Y; Kobayashi M; Naka T; Takahashi Y; Blood Purif; 2012; 33(4):252-6. PubMed ID: 22472324 [TBL] [Abstract][Full Text] [Related]
13. Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock. Ishizuka M; Terasaki A; Kubota K J Surg Res; 2016 Jan; 200(1):308-14. PubMed ID: 26319975 [TBL] [Abstract][Full Text] [Related]
14. Direct hemoperfusion with a polymyxin B column versus vasopressin for gram negative septic shock: a matched cohort study of the effect on survival. Sawa N; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hoshino J; Suwabe T; Uchida N; Wake A; Taniguchi S; Takaichi K Clin Nephrol; 2013 Jun; 79(6):463-70. PubMed ID: 23253903 [TBL] [Abstract][Full Text] [Related]
15. Early use of polymyxin B hemoperfusion in patients with septic shock due to peritonitis: a multicenter randomized control trial. Payen DM; Guilhot J; Launey Y; Lukaszewicz AC; Kaaki M; Veber B; Pottecher J; Joannes-Boyau O; Martin-Lefevre L; Jabaudon M; Mimoz O; Coudroy R; Ferrandière M; Kipnis E; Vela C; Chevallier S; Mallat J; Robert R; Intensive Care Med; 2015 Jun; 41(6):975-84. PubMed ID: 25862039 [TBL] [Abstract][Full Text] [Related]
16. Urinary liver-type fatty acid-binding protein in septic shock: effect of polymyxin B-immobilized fiber hemoperfusion. Nakamura T; Sugaya T; Koide H Shock; 2009 May; 31(5):454-9. PubMed ID: 18838948 [TBL] [Abstract][Full Text] [Related]
17. Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion. Ishizuka M; Tago K; Kubota K Surgery; 2014 Jul; 156(1):168-75. PubMed ID: 24929766 [TBL] [Abstract][Full Text] [Related]
18. Early induction of direct hemoperfusion with a polymyxin-B immobilized column is associated with amelioration of hemodynamic derangement and mortality in patients with septic shock. Chihara S; Masuda Y; Tatsumi H; Nakano K; Shimada T; Murohashi T; Yamakage M J Artif Organs; 2017 Mar; 20(1):71-75. PubMed ID: 27469940 [TBL] [Abstract][Full Text] [Related]